Clinical efficacy of blood gamma globulin treating refractory mycoplasma pneumoniae pneumonia
Feng Daoying
Abstract：Objective To investigate the clinicai effect of blood gamma globulin treating refractory mycoplasma pneumoniae pneumonia.Methods A total of 64 patients with refractory mycoplasma pneumoniae pneumonia were enrolled from our hospital from March 2012 to December 2012,and they were randomly divided into observation group and control group ; each group contained 32 cases.The two groups of patients were given antibiotics,cough and phlegm,oxygen,sedation,aerosol inhaiation and other conventional treatment.Observation group on the basis of the conventional treatment plus human blood gamma globulin treatment.Results After the treatment,the total cure rate of the observation group was 96.9％ (31/32).The differences were significant between the two groups(P ＜ 0.05).The time of cough relieve,temperature recover and length of stay of the observation group were significantly shorter than those of the control group[(9.7 ± 1.9) d vs (12.4 ± 2.2) d,(8.3 ± 1.1) d vs (11.2 ± 1.0)d,(10.3 ±2.1)d vs(12.2 ±2.4)d,P ＜0.05].There were significant differences ofCD3 +,CD4 +and CD8 + between the two groups (P ＜ 0.05).Conclusion Based on the conventional treatment,the use of blood gamma globulin in treatment of refractory mycoplasma pneumoniae pneumonia is good and worthy of clinical application.
Keywords：Mycoplasma pneumoniae pneumoniaGamma globulinRefractoriness
Publication Date：2014-07-30
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：3( 976-978 )